Interleukin-22 Promotes T Helper 1 (Th1)/Th17 Immunity in Chlamydial Lung Infection
- 32 Downloads
The role of interleukin-22 (IL-22) in intracellular bacterial infections is a controversial issue, although the contribution of this cytokine to host defense against extracellular bacterial pathogens has been well established. In this study, we focused on an intracellular bacterium, Chlamydia, and evaluated the production and function of IL-22 in host defense against chlamydial lung infection using a mouse model. We found that Chlamydia muridarum infection elicited quick IL-22 responses in the lung, which increased during infection and were reduced when bacterial loads decreased. More importantly, blockade of endogenous IL-22 using neutralizing anti-IL-22 monoclonal antibodies (mAb) resulted in more severe disease in the mice, leading to significantly higher weight loss and bacterial growth and much more severe pathological changes than treatment with isotype control antibody. Immunological analyses identified significantly lower T helper 1 (Th1) and Th17 responses in the IL-22-neutralized mice. In contrast, intranasal administration of exogenous IL-22 significantly enhanced protection following chlamydial lung infection, which was associated with a significant increase of Th17 response. The data demonstrate that IL-22 is a critical cytokine, mediating host defense against chlamydial lung infection and coordinating the function of distinct Th-cell subsets, particularly Th1 and Th17, in the process.
As a member of the interleukin-10 (IL-10) family, IL-22 is an important cytokine for modulating inflammatory responses (1). IL-22 can be produced by innate and adaptive immune cell populations, most notably T helper 17 (Th17) cells, and γβ T cells, natural killer T cells (NKT cells), lymphoid tissue inducer (LTi) cells, and LTi-like cells (2,3). IL-22 targets to various tissues, including the lung, gut, skin, liver, pancreas and kidney, for biological function (4, 5, 6). The reported biological functions of IL-22 include upregulation of antimicrobial proteins and enhancement of regeneration and innate immunity (4, 5, 6). Recent studies have demonstrated that IL-22 is involved in host defense against infections caused by various bacteria, fungi, viruses and parasites (7, 8, 9, 10, 11). For bacterial infection, it is generally accepted that IL-22 plays a protective role in extracellular bacterial infections, such as Citrobactor rodentium (6), Klebsiella pneumoniae (7) and segmented filamentous bacterium (SFB) (12), but its role in intracellular bacterial infections remains largely unclear. In the limited studies on intracellular bacterial infections, IL-22 was found redundant for Francisella tularensis (13) and Listeria monocytogenes (14) infections, although its role in Mycobacterium tuberculosis infection appeared inconsistent (15,16).
Chlamydiae are obligate intracellular bacterial pathogens, causing multiple human diseases. In particular, Chlamydia trachomatis and Chlamydia pneumonia are responsible for various human diseases in different organs. C. pneumoniae causes respiratory diseases such as bronchitis, sinusitis and pneumonia, while C. trachomatis is a major cause of ocular and genital tract sexually transmitted diseases (17). Chlamydia muridarum (Cm), a mouse strain of Chlamydiae, has been widely used in mouse models of respiratory and genital tract infections (18). Studies in clinical settings and using mouse models have demonstrated the critical importance of type 1 T-cell immunity characterized by interferon-γ (IFN-γ) production in controlling chlamydial infection (19, 20, 21). Recent studies by us and others have indicated that IL-17/Th17 also plays an important role in host defense against chlamydial lung infection (22, 23, 24, 25). In particular, IL-17 can promote Th1 responses in chlamydial lung infection and work synergistically with Th1 for inhibiting chlamydial growth (22, 23, 24, 25). Therefore, the codevelopment of sufficient Th1- and Th17-cell immune responses is important for the host to effectively control the infection and reduce pathologic damages.
Both IL-22 and IL-17 can be produced by Th17 cells, and there are data to suggest that IL-17 and IL-22 can cooperate in host defense against extracellular bacterial infections. Jha et al. have shown spontaneous release of IL-22 and IL-17 in cervical washes of women with C. trachomatis infection (26). Based on the importance of the Th17 response in host defense against chlamydial infection and the nature of Chlamydia as an intracellular bacterial pathogen, we evaluated, in the present study, the role of IL-22 in this well-established mouse lung infection model. We examined the kinetics of the IL-22 response in local tissue following Cm lung infection and specifically tested the role of IL-22 in host defense against the infection by neutralization and supplementation of this cytokine in the lung. We found that IL-22 production increased quickly following intranasal infection and reduced when bacterial loads decreased. The neutralization of IL-22 showed significant detrimental effects on the host. We found much more severe disease, indicated by higher body weight loss, bacterial growth and more severe pathological damage, in the IL-22-neutralized mice compared with the isotype control antibody sham-treated mice, results that were associated with downregulation of Th1 and Th17 cell responses. Moreover, administration of exogenous IL-22 enhanced protection and increased IL-17/Th17 responses. The data suggest that IL-22 plays an important role in host defense against chlamydial lung infection through modulating the pattern of T-cell responses.
Materials and Methods
Male C57BL/6 mice (6–8 wks old) were purchased from the University of Manitoba animal care facility. The mice were hosted at a pathogen-free laminar flow cabinet. All animal experiments were conducted in compliance with the guidelines issued by the Canadian Council for Animal Care, and the research protocol was approved by the Protocol Management and Review Committee of the University of Manitoba.
C. muridarum organisms (Nigg strain) were cultured, purified, and quantified as previously described (27). Briefly, C. muridarum was grown in HeLa 229 cells in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS), 1% L-glutamine, and 25 mg/mL gentamycin, and the elementary bodies (EBs) were purified by discontinuous density gradient centrifugation. The infectivity of purified EBs was measured by infecting Hela 229 and immunostaining of chlamydial inclusions. The purified EBs were suspended in sucrose-phosphate-glutamic acid (SPG) buffer and stored at −80°C. The same batch of purified EBs was used throughout this study.
Mouse Infection and Treatment
Mice were intranasally inoculated with 1 × 103 inclusion-forming units (IFU) of C. muridarum EBs in 40 µL SPG buffer, and the same volume of SPG buffer was administrated for the sham-inoculated group. For IL-22 blockade experiments, mice were intranasally administered 10 µL (40 µL) of either rat IgG2a anti-mouse IL-22 monoclonal antibody (mAb) (catalog number 16-7222; eBioscience, San Diego, CA, USA) or rat IgG2a isotype control (catalog number 16-4321; eBioscience) at 1 d before, the same day, and every 2 d after the intranasal infection. For application of exogenous IL-22, each mouse was intranasally given 0.2µg mouse recombinant IL-22 (carrier free) (catalog number 582-ML/CF; R&D Systems, Minneapolis, MN, USA) in 30 µL sterile phosphate-buffered solution (PBS) using the same interventional strategy as in the IL-22-blockade experiments. The control mice were sham treated with an equal volume of sterile PBS. Mice were sacrificed at d 7, d 12 and d 21 postinfection. Lung tissues were removed and homogenized in 3 mL SPG buffer. After centrifugation to clear residual debris, the homogenates were used to measure live chlamydial organisms and cytokines (IL-17, IL-22 and IFN-γ) as previously described (28).
Analysis of Lung Pathology
The lung tissues of mice were perfused with PBS and fixed in 10% formalin. The tissue sections were routinely stained with hematoxylin and eosin (H&E) and examined under light microscopy as described (25,29). The degree of lung inflammation was scored using a semiquantitative grading system (25); grading scale: 0, normal; 1, mild and limited inflammation, granuloma formation, cellular infiltration in less than 25% of area, no obvious infiltration into adjacent alveolar septae or air space; 2, mild interstitial pneumonitis, diffused cellular infiltration in some area (25%–50%), septal congestion, interstitial edema; 3, inflammatory cell infiltration into perivascular, peribronchiolar, alveolar septae, and air space (50%–75% of area); 4, over 75% of area of lung filled with infiltrating cells.
Lung, Spleen and Local Lymph Node Cell Isolation
Lung, spleen and draining lymph node (LN) cells were isolated for bulk culture and flow cytometry analysis as described (30,31). Briefly, lung tissues were harvested from the animals at specified times and digested in 2 mg/mL collagenase XI (Sigma-Aldrich, Oakville, Ontario, Canada) in RPMI 1640 for 1 h at 37°C. After digestion, 35% (volume/volume) Percoll (Pharmacia, Uppsala, Sweden) and ammonium-chloride-potassium (ACK) lysis buffer (150 mmol/L NH4Cl, 10 mmol/L KHCO3 and 0.1 mmol/L EDTA) were used to remove tissue debris and red blood cells (RBC), respectively. For spleen single-cell preparation, spleens were cut into small pieces and digested in 2 mg/mL collagenase D (Roche Diagnostics, Meylan, France) in RPMI 1640 for 30 min at 37°C. The cell suspension was filtered and RBCs were removed by ACK lysis buffer. For draining LN mononuclear cell isolation, the draining LNs were homogenized in 3 mL RPMI 1640 and RBCs were removed by ACK lysis buffer. All of the cells were washed and resuspended in complete RPMI-1640 medium (RPMI-1640 supplemented with 10% FBS, 1% L-glutamine, 25 mg/mL gentamicin and 0.05 mmol/L 2-mercaptoethanol). Single-cell suspensions were cultured in 48-well plates at a concentration of 7.5 × 106 (spleen) and 5 × 106 (lung and LN) cells/well with or without UV-inactivated Cm (1 × 105 IFU/mL). The supernatants were collected from the cell cultures after 3 d and assayed for IL-10, IFN-γ, IL-12p40, IL-6, IL-17 and transforming growth factor-β (TGF-β) by enzyme-linked immunosorbent assay (ELISA) using antibodies purchased from eBioscience or BD Biosciences.
Flow Cytometric Analysis
The intracellular IFN-γ-, IL-17- and IL-10-produced T cells were analyzed by intracellular cytokine staining as described previously (29). Briefly, the cells were stimulated with phorbol myfismte acetate (PMA; 50 ng/mL) and Ionomycin (1 µg/mL), and incubated at 37°C in complete RPMI 1640 medium. After 2 h, brefeldin A was added to the culture, and the cells were cultured for another 4 h to allow cytokine accumulation intracellularly. The cells were collected and blocked with anti-CD16/CD32 Abs in fluorescence-activated cell sorter (FACS) buffer for 20 min and then surface stained with anti-CD3ε-fluorescein isothiocyanate (FITC) and anti-CD4− phycoerythrin (PE) mAbs (eBioscience). After being fixed and washed in permeabilization buffer, cells were stained with anti-IFNγ-allophycocyanin, anti-IL-17-allophycocyanin and anti-IL-10-allophycocyanin mAbs (eBioscience) or with corresponding isotype control Abs for 30 min. Cells were washed twice with permeabilization buffer and analyzed by flow cytometry. All of the sample data were collected using an LSR II flow cytometer (BD Biosciences, San Diego, CA, USA) and analyzed using FACS Express software (De Novo Software, Los Angeles, CA, USA).
Reverse-Transcription Polymerase Chain Reaction (RT-PCR) Analysis for Cytokines and Transcription Factors
Total RNA of lung tissues was extracted by using TRIzol reagent according to the manufacturer’s instructions (Invitrogen/Life Technologies, Burlington, ON, Canada). A constant amount of RNA (1.5 µg per sample) was reverse transcribed into cDNA, and the cDNA was then amplified using murine-specific primers. Primer sequences were as follows: IL-22 (167 bp), forward: 5′-GACAGGTTCCAGCCCTA CAT-3′, reverse: 5′-ATCGCCTTGATCTCT CCACT-3′; IL-17 (399 bp), forward: 5′-GGTCAACCTCAAAGTCTTTAACTC-3′, reverse: 5′-TTAAAAATGCAAGTA AGTTTGCTG-3′; IFN-γ (405 bp), forward: 5′-TACTGCCACGGCACAGTCAT TGAA-3′, reverse: 5′-GCAGCGACTC CTTTTCCGCTTCCT-3′; T-bet (438 bp), forward: 5′-TGAAGCCCACACTCC TACCC-3′, reverse: 5′-GCGGCATTTT CTCAGTTGGG-3′; retinoic acid-related orphan receptor γt (RORγt) (582 bp), forward: 5′-GCGGAGCAGACACAC TTACA-3′, reverse: 5′-TTGGCAAACT CCACCACATA-3′; glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (191 bp): forward: 5′-AACGACCCCT TCATTGAC-3′, reverse: 5′-CACGA CTCATACAGCACCT-3′. Polymerase chain reaction (PCR) reaction mixtures were loaded onto a 1.5% agarose gel containing ethidium bromide, and the bands were analyzed for density on Quantity One software (Bio-Rad Laboratories, Hercules, CA, USA).
Statistical analysis of the data was performed using analysis of variance (ANOVA) and t tests (GraphPad Prism software, version 5.0 [GraphPad Software, La Jolla, CA, USA]), and values of p < 0.05 were considered significant. Data are presented as mean ± standard deviation (SD). The presented data were collected from all four mice of each group. All the experiments were repeated two to three times with similar results.
All supplementary materials are available online at www.molmed.org .
Cm Lung Infection Induces IL-22 Response
IL-22 Contributes to Protection against Cm Lung Infection
IL-22-Neutralized Mice Exhibit Reduced IL-17/Th17 Production in Chlamydial Lung Infection
Our and others’ previous works have demonstrated that IL-17 plays a protective role in host defense against chlamydial lung infection (22, 23, 24, 25). There is also evidence suggesting that IL-17 and IL-22 cooperate in host defense against some infections (32). Considering that Th17 cells can produce both IL-22 and IL-17, along with the similar kinetics of IL-22 and IL-17 responses in the lung following Cm infection (Figure 1), we hypothesized that IL-22 may influence the IL-17 response in the process. We therefore directly tested Th17 responses and related transcription factor expression as well as cytokines in the IL-22-neutralized and sham-treated (isotype control) mice following Cm infection (d-7 postinfection). Intracellular cytokine staining showed marked reduction of IL-17-producing CD4+ T cells in the lung, spleen and draining LNs of the IL-22-neutralized mice (Figures 3A-C). Analysis of mRNA expression of RORγt, the specific transcription factor controlling Th17 cell differentiation, showed significantly lower expression of this factor in the lung tissues of IL-22-neutralized mice (Figures 3D, E). At the protein level, we found that lung, spleen and draining LN cells isolated from IL-22-neutralized mice produced significantly lower levels of IL-17/Th17-promoting cytokine (IL-6) and higher levels of TGF-β than isotype control mice (Figures 3F-H). These data suggest that IL-22 can promote the production of IL-17 and the development and/or expansion of Th17 cells during chlamydial lung infection.
IL-22-Neutralized Mice Exhibit Reduced Th1 Response Following Cm Lung Infection
IL-22 Neutralization Reduces IL-10 Production In Vivo
Treatment of Mice with Exogenous IL-22 Significantly Enhances Protection against Chlamydial Pulmonary Infection
Treatment of Mice with Exogenous IL-22 Significantly Enhances Th17 Response in Cm Lung Infection
In this study, by working on a mouse model, we have shown that IL-22 plays an important role in host defense against respiratory tract infection of Chlamydia, an intracellular bacterium. The protective role of IL-22 in this infection is mainly through enhancing Th17 and Th1 immunity. This conclusion is generated form the following major findings in the study. First, we found that Cm lung infection induced quick IL-22 responses (within 24 h) in the local tissues, which peaked and then reduced during the course of infection. Second, we found that the neutralization of local IL-22 in vivo using anti-IL-22 mAb at the time of Cm infection led to more serious diseases (larger body weight loss, higher bacterial loads and more severe tissue pathology in the lung), which was associated with decreased Th17 and Th1 responses in the local tissues and draining LNs, as well as secondary lymphoid organ (spleen). Furthermore, we found that supplement of exogenous recombinant IL-22 significantly enhanced protection during lung infection, which was associated with increased Th17 responses. Aujla and colleagues found that exogenous IL-22 promoted epithelial repair and reduced the bacterial load in mice infected with Klebsiella pneumonia (7). The report was consistent with what we have observed in the present study in a Cm lung infection model. It should be noted that the administration of rIL-22 in this study is only a proof-of-concept experiment, which confirms the involvement of IL-22 in host defense against chlamydial infection. The therapeutic potential of this cytokine, if any, in chlamydial diseases is yet to be tested by comprehensive study. Overall, the data suggest an important role of IL-22 in coordinating Th17/Th1 reduring an intracellular bacterial lung infection and ultimately controlling the infection.
The use of both blockade and supplement approaches in the study is helpful for understanding the effect of IL-22 on distinct T-cell subsets during the infection. The neutralization experiments showed reduction of both Th1 and Th17 responses, which may suggest that IL-22 promotes both cells directly. However, the supplement experiment showed that the administration of exogenous recombinant IL-22 enhanced IL-17/Th17 responses, but not Th1 response. The data suggest that the reduced Th1 response observed in the neutralization experiments is more likely a result of reduced Th17 responses in the IL-22-blocked mice. Indeed, we have reported that IL-17 can promote Th1 responses in chlamydial lung infection through modulating dendritic cell function, particularly for IL-12 production by dendritic cells (22). The mechanism for the promoting effect of IL-22 on IL-17 may be related to multiple factors but its effect on IL-17-promoting cytokines could be one of the major reasons. We found that blockade of IL-22 caused significant reduction of IL-6 but increase of TGF-β production following Cm lung infection. Recent research has demonstrated that IL-6 and TGF-β play important roles in regulating the balance between Th17 cells and regulatory T cells (Treg) (34). Although TGF-β is needed for the development of both Treg and Th17 responses because of its inducing effect on both RORγt and Foxp3 expression (35), IL-6 is a critical cytokine determining Th17 response. Under the conditions of sufficient TGF-β production, high levels of IL-6 can remove the inhibition of Foxp3 on RORγt, and thus switch the response from Treg to Th17. The cytokine pattern change (reduced IL-6 production with increased TGF-β production) in IL-22 neutralized mice is more suitable for the development of Treg rather than Th17 cells (34, 35, 36). Consistently, we found significantly increased CD4+ CD25+ Foxp3+ T cells and surface TGF-β expressing CD4+ cells in the IL-22-neutralized mice, indicating enhanced Treg populations (data not shown). In line with the inhibitory effect of IL-22 on Treg responses, the observed promoting effect of it on Th1 response is possibly through indirectly enhancing Th17 and inhibiting Treg.
Although our focus in the present study is mainly on the production of these cytokines by CD4+ T cells at d 7 and later times of infection, the effect of IL-22 on IL-17 and IFN-γ production appears not only through influencing CD4+ T cells. As shown in Figure 1, these cytokines started to increase at earlier times, including d 3 postinfection. At this early time point, we found that anti-IL-22 treatment significantly reduced the levels of these cytokines in the lung homogenates; however, the measurement of intracellular cytokine staining of CD4+ T cells failed to show differences between the two groups (Supplementary Figure S2). The data suggest that IL-22 also influences IL-17 and IFN-γ production by nonclassical T cells, particularly in the early point of infection. These non-classical cells are likely to include yôT cells, NKT cells and others.
The reason for the failure to show influence of exogenous IL-22 on the Th1 response in the supplement experiments is probably because a sufficient amount of endogenous IL-22 already existed in the normal (sham-treated) mice, which can generate enough IL-17 to promote Th1 and inhibit Treg. Therefore, the observed better protection in the exogenous IL-22 treated mice is more likely due to the higher IL-17 production caused by the treatment, which synergizes with IFN-γ to inhibit chlamydial growth. However, the potential direct promoting effect of IL-22 on the Th1 response still cannot be completely excluded because IL-22 may be needed for the background or normal levels of IFN-γ production, although the excessive levels of IFN-γ may not need IL-22. This is possible, especially considering that IL-22 is produced by different types of immune cells, particularly including Th1 cells. Notably, in the mouse system, the IL-22 gene was mapped on chromosome 10, the same region as the IFN-γ (37). Thus, the alternation in the expression of IL-22 might influence the regulation of IFN-γ gene expression.
In this study, IL-22-neutralized mice exhibited significantly lower levels of IL-10 production than sham-treated mice. In addition, the IL-10–producing CD4+ T cells in the different organs were also significantly reduced in the IL-22-neutralized mice. This contradicts our initial prediction that the Th1/Th17 reduction in IL-22–neutralized mice may be accompanied by high IL-10 production, which has been shown to be inhibitory for Th1/Th17 responses. However, the findings may reflect the complement effect between IL-10 and IL-22. The receptor for IL-22 is composed of IL-22R1 and IL-10R2 (38). IL-10R2 is also a component of the receptor complex for IL-10 (IL-10R1/IL-10R2) (38). The early signal transduction pathways, such as activation of signal transducers and activators of transcription (STAT1)/STAT3 and the subsequent induction of mRNA for suppressor of cytokine signaling 3 (SOCS3), are similar between IL-22 and IL-10, likely because of the common usage of IL-10R2 receptor by both cytokines (39). Therefore, IL-22 and IL-10 are closely linked in the inflammatory reactions. Nagalakshmi et al. found that the IL-22 response had a positive correlationin with the IL-10 response in intestinal inflammation, showing that neutralization of IL-22 significantly reduced IL-10 production (40). That report was consistent with what we have observed in the present study in the Cm lung infection model. The finding of lower IL-10 production in the IL-22–neutralized mice further confirms the direct promoting effect of Th1/Th17 responses. In addition, the data suggest that, although lower IL-10 has been found to be associated with better protection in chlamydial lung infection (20), lower IL-10 alone is not sufficient for protection. In contrast, higher Th1 and Th17 responses are critical for protection.
In summary, our data show that IL-22 is a critical cytokine in determining the development and/or expansion of distinct T cell subsets, including Th1 and Th17, during respiratory tract infection by Chlamydia. The study provides new evidence supporting the importance of IL-22 in intracellular bacterial infection. The demonstration of the critical role of IL-22 in enhancing protective Th17/Th1 responses may have implications in the development and improvement of preventive and therapeutic approaches for chlamydial diseases.
The authors declare that they have no competing interests as defined by Molecular Medicine, or other interests that might be perceived to influence the results and discussion reported in this paper.
This work was supported by grants from the Canadian Institutes of Health Research to X Yang (CCI92213 and CIHR/RPA-124955) and grants from the National Natural Sciences Foundation of China (#30811120425 and #81271853) to W Zhao. Y Peng was a recipient of a PhD Studentship for Overseas Study from Shandong University.
- 38.Kotenko SV, et al. (2001) Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol. Chem. 276:2725–32.CrossRefPubMedGoogle Scholar
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.
The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this license, visit (https://doi.org/creativecommons.org/licenses/by-nc-nd/4.0/)